Primis Financial Corp. (NASDAQ:FRST) Q4 2022 Earnings Call Transcript
Primis Financial Corp. (NASDAQ:FRST) Q4 2022 Earnings Call Transcript January 27, 2023
Operator: Hello and thank you for standing by. My name is Regina and I will be your conference operator today. At this time, I would like to welcome everyone to Primis Financial Corporation Fourth Quarter Earnings Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. I would now like to turn today's conference over to Matt Switzer, Chief Financial Officer. Please go ahead.
Matthew Switzer: Good morning and thank you for joining us for Primis Financial Corps' 2022 fourth quarter webcast and conference call. Before we begin, please note that many of our comments during this call will be forward-looking statements, which involve risk and uncertainty. There are many factors that could cause actual results to differ materially from the anticipated results or other expectations expressed in the forward-looking statements. Further discussion of the company's risk factors and other important information regarding our forward-looking statements are part of our recent filings with the Securities and Exchange Commission, including our recently filed earnings release, which has also been posted to the Investor Relations section of our corporate site, primisbank.com.
We undertake no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results over time. In addition, some of the financial measures that we may discuss this morning are non-GAAP financial measures. A reconciliation of the non-GAAP measures to the most comparable GAAP measures can be found in our earnings release. With that, I will now turn the call over to our President and Chief Executive Officer, Dennis Zember.
Dennis Zember: Thank you, Matt and thank you to all of you that have joined our fourth quarter conference call. When we started 2022, we were determined to grow our new lines of business alongside the community bank to finish the work that we'd started on the digital bank, and to somehow diversify away from just spread income, wanting to build some strength and opportunity and non-interest income, which our company had not really benefited from. Looking back over the last 12 months, we've invested so hard in the bank that we envision. And the question, or one of the questions that we all have is basically, will it pay off and win? I'm going to answer that in a minute, but first, a few items to highlight in the quarter and in the year.
First was the loan growth we experienced. I knew Matt was conservatively estimating our growth potential. He's chuckling right now, as we started 2022, and we did come in very strong with about 25% growth in loans when you exclude the effects of PPP. And this was from all areas of the bank, just like we had predicted evenly from the community bank, from Panacea and from Life Premium Finance. For almost five years really through the middle of last year, our bank had just not grown loans organically that's we were not known for that. And I think we've turned that around in a really big way and I'm really proud of the engine that we have built here from scratch. Two of these engines are operating lines of business. Panacea started the year with only about $50 million of loans, all consumer and about $1.3 million of recurring revenue.
We grew our doctor base to about 3000 doctors doing business with us all across the country. We've invested in production and credit administration and customer support and technology. We spent all this money to build the brand and as we progressed through the year, results at Panacea progressed nicely. We finished a year with about $7 million of recurring revenue and the prospect of a material boost to that number as we move to start splitting our production between gains -- between -- excuse me -- between gain on sales and portfolio. The credit here is outstanding. Our commercial book has debt coverages in the -- over 2% -- or excuse me -- over two times. No past dues ever and incremental yields honestly that are close to or exceeding traditional bank CRE.
Like Premium Finance ended with just $200 million, just under $200 million of outstanding loans and about $800 million underwritten. In less in a year they've built a brand and all the infrastructure and can take this to something much more sizable with where the only real incremental operating expense is hiring incentive pay for the producers. This division also moved yields higher on loans that are entirely cash secured, and in the fourth quarter we are getting incremental variable rate yields within 30 to 40 basis points of fixed rate CRE. Another area we invested in was the mortgage business, and our total investment in the Mortgage company, including the losses associated with recruiting the teams, stands at just under $6 million, which is considerably less than our former investment in Southern Trust.
Photo by Alexander Mils on Unsplash
Looking at our production teams, our restructured comp plans, the level of administrative -- excuse me -- the level of administrative staffing and the current rate and housing environment, I feel confident that this investment has a payback of about four or five quarters. We are not so heavily invested in this space that we can't maneuver or pivot if conditions worsen or recruit and build if conditions for this space improve. I mean, I really believe we're ideally positioned for this year and this division will improve our earnings and ROA in 2023. The last thing I'd mentioned -- next to last thing I'd mentioned really before turning this back to Matt is in regards to credit quality. During the quarter we took a very large provision for a single asset, one that we had put in non-performers I think in the third quarter.
When this loan got wobbly, we got new appraisals and we felt pretty confident in our position, but we reappraised the properties in the fourth quarter and aggressively wrote them down to the 90-day liquidation value and levels that I'm hopeful will move the property as soon as we're able to do so. The other material MPA on our books is the first mortgage on the largest state property. We have a 40% or so LTB there, three junior lien holders behind us, and right now that loan is current, but we have left it in non-performers for the time being. So outside of these two credits, we only have about 20 basis points of non-performers, and our credit quality in 2022 would have improved dramatically, almost about 50% and to the near -- and nearly to the top of our peer group.
And none of that, actually -- none of that excuses our actual results. We finished a year with about 119 basis points of non-performers, and I'm just trying to illustrate to you how determined we are to move these two assets out of the bank as fast as we can and restore credit quality that you'd expect from a top performing bank. That can -- how I started about investing in the bank. It is not easy to grow a bank this size organically, especially at the pace that we're trying to grow. It's, gut wrenching actually. It takes about 18 months to conceive a strategy, build it out, suffer some operating losses that us CEOs like to call investments, stay the course while you make small adjustments here and there while you're second guessed, and then finally come out on the other side with something that drives value.
The outset for me here about three years ago, I saw some issues that I thought were standing in the way of us creating long-term shareholder value and we've invested a lot of our dollars and operating results. And honestly, a lot of myself personally, building engines that I know unquestionably drive value in this industry. We needed a safe way to grow loans. We needed reliable sources of non-interest income. We needed more deposit strategies. We needed more expertise in every area of the bank. We needed better regulatory reputations relationships. We needed a better brand. And just saying all that leads me out of breath. The good news for 2023 is that we don't have a lot left to invest in. What we've done over the last three years, and especially in 2022, is enough to produce outsized growth and profitability for some time.
In 2023 we need to let all of that come to fruition. And I believe that we'll see all of this build and start to pay off and I'm determined with Matt's help to not be distracted with any other -- with anything else other than getting the payback on these investments and honestly illustrating how great a value our stock is at these levels. Alright, Matt, with that, I will turn it back to you.
Matthew Switzer: Thanks Dennis. I will provide a brief overview of our results before we turn to a Q&A. But as a reminder, a full description of our fourth quarter results can be found in our earnings release in fourth quarter earnings presentation, both of which can be found on our website. Earnings from continuing operations for the fourth quarter were $3.1 million or $0.12 per diluted share versus $5.1 million or $0.20 per diluted share in the third quarter. Excluding one time items, earnings in the fourth quarter were $0.03 per diluted share versus $0.21 in the third quarter. As Dennis mentioned, as I'll discuss further, earnings were impacted by a large provision and mortgage related losses in the fourth quarter. Total assets were $3.57 billion at December 31 versus $3.36 billion at September 30.
Excluding PPP loans and loans held for sale, loan balances grew 32% annualized in the fourth quarter, both was primarily driven by Panacea and Life Premium Finance again in Q4, but we did see growth in the core bank as well. Given the rate environment, we did not expect this level of loan growth to continue at this pace in 2023. Deposits were up approximately 2% annualized in Q4. Non-interest bearing deposits declined to 21.4% from 25.4% last quarter as depositors began looking for yield. Our loan to deposit ratio increased to 108% in the fourth quarter, which is higher than we prefer, and we are singularly focused on bringing that ratio down in Q1 of this year. Excluding accounting adjustments, net interest income increased to $28.2 million from $27.5 million in Q3.
Excluding these same adjustments plus effects of PPP, our margin was 3.51%, down 7 basis points from the third quarter. Adjusted yield on earning assets expanded 35 basis points, while cost of deposits and cost of funds increased 30 basis points and 48 basis points, respectively from Q3. Excluding accounting adjustments and one time gain, non-interest income was $5 million versus $4.4 million in the third quarter. Large originations were up 36% in Q4 in the face of substantial industry headwinds and on top of normal seasonal lows for mortgage. The additional teams we added late in the third quarter are fully onboarded and building pipelines. We're projecting originations of $1 billion in 2023 including and taking into account the current environment and up from roughly $300 million in 2022 and with meaningful additions to non-interest income and profitability overall.
Non-interest expense included a number of items this quarter, including $1.2 million of non-recurring expenses, $36,000 for unfunded commitment reserve and increase mortgage expenses of roughly $2.2 million from a full quarter of the production team buildout that we started late in Q3. Excluding these items, non-interest expense was $21.2 million up from $20 million last quarter. While we intend to moderate them in the first quarter, marketing costs remained high in the fourth quarter. Turnover in the organization continues to cause inflationary pressures and salary and benefits. We also had approximately $500,000 of year-end true ups for various accruals. As we look to the first quarter, we expect cost controls to push expenses down slightly from Q4.
Excluding non-recurring accounting adjustments and the impact of mortgage, our operating efficiency was just under 70% in Q4. Mortgage improvement, which is expected to be breakeven in the first quarter, plus increasing operating leverage from Panacea and Life Premium Finance will drive this efficiency ratio lower in 2023. As Dennis alluded to the provision for credit losses was $7.86 million in the fourth quarter versus $2.89 million in Q3. Excluding accounting related adjustments, the provision would've been $6 million in the fourth quarter, with the increase largely due to the impairment of the relationship that Dennis discussed earlier. We also had net charge-offs in the fourth quarter of $3.7 million excluding accounting adjustments, again largely tied to the relationship discussed previously and offset partly by $1.3 million of recoveries in the quarter.
Taken all together, the allowance for credit losses to gross loans, excluding PPP was flat at 117 basis points at December 31. Non-performing assets net of SBA guarantees decreased to $34.9 million in the fourth quarter from $36.1 million last quarter. The relationship we've previously discussed along with the other loan that Dennis mentioned combined are 78% of our non-performing loans. We also now have no OREO as of December 31. Pretax, pre-provision operating ROA was 78 basis points in Q4, down from 105 basis points in Q3. Excluding the investment in Mortgage, this ratio would've been approximately 110 basis points versus 115 last quarter. Similar to the efficiency ratio discussion above, we expect meaningful contributions from our newest business lines, including Mortgage, Panacea, and Life Premium Finance in 2023 that will materially increase profitability and drive us to our 1% ROA goal.
With that, operator, we can now open the line for Q&A.
See also 12 Cheap Biotech Stocks To Buy and 12 Best Low Priced Dividend Stocks To Buy.
To continue reading the Q&A session, please click here.
